RecruitingPhase 3NCT05908084
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
Studying Complication in hemodialysis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Humacyte, Inc.
- Intervention
- Acellular Tissue Engineered Vessel (ATEV)(biological)
- Enrollment
- 150 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2023 – 2027
Study locations (30)
- Honor Health Scottsdale Shea Medical Center, Scottsdale, Arizona, United States
- El Centro Regional Medical Center, El Centro, California, United States
- Jacob's Medical Center at UC San Diego Health, La Jolla, California, United States
- Denver Health and Hospital Authority, Denver, Colorado, United States
- Yale New Haven Hospital, New Haven, Connecticut, United States
- Access Research Institute, Brooksville, Florida, United States
- University of FL Health Heart and Vascular Hospital, Gainesville, Florida, United States
- Mayo Clinic Florida, Jacksonville, Florida, United States
- American Access Care of Miami, LLC, Miami, Florida, United States
- USF Health South Tampa, Tampa, Florida, United States
- Georgia Nephrology, Atlanta, Georgia, United States
- Grady Memorial Hospital, Atlanta, Georgia, United States
- IU Health Bloomington Hospital, Bloomington, Indiana, United States
- John Hopkins University School of Medicine, Baltimore, Maryland, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
IQVIA Biotech
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05908084 on ClinicalTrials.govOther trials for Complication in hemodialysis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07438925Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure VariationCentral Hospital, Nancy, France
- RECRUITINGNANCT06341452Comparison of Individualized Sodium Management Versus Standard Treatment in HemodialysisFresenius Medical Care Deutschland GmbH
- RECRUITINGNANCT07512895The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treatment: A Randomized Controlled TrialIstanbul Aydın University
- RECRUITINGNANCT07269379Intradialytic Exercise With Blood Flow Restriction in Hemodialysis PatientsUniversity of Avignon
- ACTIVE NOT RECRUITINGNCT07412834Safely Disconnect From the Dialysis Machine in an Emergency SituationIstanbul University
- RECRUITINGPHASE1NCT07217886A Study of S-892216-PO in Participants With Renal Impairment and Matched ControlsShionogi
- RECRUITINGNANCT06978127Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis PatientsUniversity of Pittsburgh
- ACTIVE NOT RECRUITINGPHASE3NCT06901505To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisAkebia Therapeutics